The Problems and Challenges of Immunotherapy in Sepsis
The Problems and Challenges of Immunotherapy in Sepsis
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Despite decades of research, the morbidity and mortality of sepsis and septic shock remain very high. To further compound the problem, results from all investigative trials (with one exception) have shown that tested immunotherapies aimed at modulating the excessive expression of key cytokines, such as the interleukins and tumor necrosis factor, ha...
Alternative Titles
Full title
The Problems and Challenges of Immunotherapy in Sepsis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_73292297
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_73292297
Other Identifiers
ISSN
0012-3692
E-ISSN
1931-3543
DOI
10.1378/chest.123.5_suppl.451S
